SMAD2 and pulmonary arterial hypertension: We found, however, that human PAH PAVSMC, while secreting high amounts of active TGF-β1 and/or Activin A, had reduced activatory phosphorylation of both, Ser465/467-Smad2 and Ser423/425-Smad3.